New · CUSIP 008064206 · who reports it, how much, and how much it matters to them
25 of the 720 hedge fund managers we track reported shares of Jade Biosciences, Inc. (Nasdaq: JBIO) on Form 13F for 30 June 2026. Between them they reported USD 405m. The largest position belongs to Fairmount Funds Management, at USD 101m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management2 funds on PPLI.com | USD 101m | 6.7% |
| 2 | Ra Capital Management1 fund on PPLI.com | USD 82m | 0.7% |
| 3 | Adage Capital Management1 fund on PPLI.com | USD 42m | 0.1% |
| 4 | Polar Capital LLP26 funds on PPLI.com | USD 41m | 0.1% |
| 5 | Baker Bros. Advisors2 funds on PPLI.com | USD 27m | 0.1% |
| 6 | Logos Global Management1 fund on PPLI.com | USD 25m | 1.1% |
| 7 | Citadel Advisors32 funds on PPLI.com | USD 21m | 0.0% |
| 8 | Balyasny Asset Management25 funds on PPLI.com | USD 20m | 0.0% |
| 9 | Marshall Wace LLP84 funds on PPLI.com | USD 13m | 0.0% |
| 10 | Walleye Capital8 funds on PPLI.com | USD 8.1m | 0.0% |
| 11 | Millennium Management6 funds on PPLI.com | USD 7m | 0.0% |
| 12 | POINT72 Asset Management17 funds on PPLI.com | USD 3.7m | 0.0% |
| 13 | Boothbay Fund Management2 funds on PPLI.com | USD 2.5m | 0.0% |
| 14 | Sofinnova Investments1 fund on PPLI.com | USD 2.4m | 0.1% |
| 15 | Renaissance Technologies13 funds on PPLI.com | USD 1.6m | 0.0% |
| 16 | Verdad Advisers6 funds on PPLI.com | USD 1.3m | 1.2% |
| 17 | Squarepoint Ops7 funds on PPLI.com | USD 1.2m | 0.0% |
| 18 | D. E. Shaw & Co.15 funds on PPLI.com | USD 1.1m | 0.0% |
| 19 | Voloridge Investment Management6 funds on PPLI.com | USD 1.1m | 0.0% |
| 20 | Two Sigma Investments35 funds on PPLI.com | USD 1m | 0.0% |
| 21 | Voleon Capital Management13 funds on PPLI.com | USD 617,000 | 0.0% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 503,000 | 0.0% |
| 23 | Aquatic Capital Management3 funds on PPLI.com | USD 498,000 | 0.0% |
| 24 | Brevan Howard Capital Management39 funds on PPLI.com | USD 216,000 | 0.0% |
| 25 | The Quarry1 fund on PPLI.com | USD 867 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management | USD 101m | 6.7% |
| 2 | Verdad Advisers | USD 1.3m | 1.2% |
| 3 | Logos Global Management | USD 25m | 1.1% |
| 4 | Ra Capital Management | USD 82m | 0.7% |
| 5 | Baker Bros. Advisors | USD 27m | 0.1% |
| 6 | Sofinnova Investments | USD 2.4m | 0.1% |
| 7 | Polar Capital LLP | USD 41m | 0.1% |
| 8 | Adage Capital Management | USD 42m | 0.1% |
| 9 | Boothbay Fund Management | USD 2.5m | 0.0% |
| 10 | Walleye Capital | USD 8.1m | 0.0% |
Jade Biosciences, Inc. trades under the symbol JBIO on the Nasdaq. Its CUSIP, the code used on Form 13F, is 008064206.
25 of the 720 hedge fund managers PPLI.com tracks reported Jade Biosciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 101m), Ra Capital Management (USD 82m), Adage Capital Management (USD 42m), Polar Capital LLP (USD 41m) and Baker Bros. Advisors (USD 27m).
25 managers in our coverage reported it, and between them they run 347 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Fairmount Funds Management, where the position was 6.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Jade Biosciences, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.